Dr Hsia was formerly senior vice president of scientific affairs at Watson Pharmaceuticals before his retirement. Dr Hsia has received a PhD in industrial and physical pharmacy from Purdue University in 1975.
Johnson Lau, executive chairman of the board at Kinex, said: “As the company moves forward, we look forward to leveraging the full breadth of David’s expertise as a board member to assist us in developing our new drug candidates.”